- DSpace Principal
- →
- Neurología
- →
- Enfermedades Desmielinizantes
- →
- Enfermedades Desmielinizantes.pósters
- Políticas del Repositorio
- Contacto y sugerencias
JavaScript is disabled for your browser. Some features of this site may not work without it.
Enfermedades Desmielinizantes.pósters
Listar por
Envíos recientes
-
(American Academy of Neurology, 2024-04-09)Objective: To analyze characteristics of patients with secondary progressive Multiple Sclerosis (SPMS) exhibiting Progression Independent of Relapse Activity (PIRA) and to identify factors contributing to earlier ...
-
(American Academy of Neurology, 2024-03-09)
-
(Reunión de Sociedades de Biociencias, 2021-11)Recent reports show that astrocytes (AST) are able to create a permissive environment for remyelination through their action on oligodendrocyte (OLG) precursor migration, proliferation, and differentiation. When ...
-
(37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, 2021-10)Resumen no disponible
-
(AAN, 2019-05-09)Objective: To analyze the volumetric and density characteristics of the extraocular muscles (EOM) in patients with Myasthenia Gravis (MG). Background: MG is an autoimmune disease that mainly involves EOM. Myopathies ...
-
(AAN, 2019-05-07)Objective: To obtain in-vivo evidence of early dynamics of multiple sclerosis (MS) lesions formation and changes that corticosteroids may induce. Background: MRI showed that the development of MS lesions is dynamic and ...
-
(AAN, 2019-04-16)Objective: To investigate cytotoxic activity heterogeneity in MAIT cell populations from MS patients Background: MAIT cells are a subset of innate T lymphocytes characterized by expression of an invariant TCR α-chain ...
-
(AAN, 2019-04-16)Objective: The objective of this study is to differentiate the clinical presentation, complementary studies and evolution between the Systemic Vasculitis (SV) vs Non-Systemic Vasculitic Neuropathy (NSVN) attended in our ...
-
(AAN, 2019-04-09)Objective: To identify clinical-radiological characteristics of patients consulting with suspected Late Onset Multiple Sclerosis (LOMS). Background: LOMS is defined by clinical presentation after 50 years of age, being ...
-
The Natural History of Primary Progressive Multiple Sclerosis in Buenos Aires, Argentina (P4.2-070) (Lippincott Williams & Wilkins, 2019-04-16)Objective: To assess if clinical relapses and radiological disease activity correlates with neurological disability in primary progressive multiple sclerosis (PPMS), and to determine if there is any correlation between ...
-
(Lippincott Williams & Wilkins, 2019-04-16)Objective: To present the baseline characteristics of patients enrolled in the ASCLEPIOS I and II trials. Background: ASCLEPIOS I and II are two Phase 3 trials of identical design that are being conducted simultaneously ...
Atribución 4.0 Internacional (CC BY 4.0)